Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Rissmann

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Experimental Dermatology|November 11, 2023
A Phase 1 randomized, open-label clinical trial to evaluate the effect of a far-infrared emitting patch on local skin perfusion, microcirculation and oxygenationSebastiaan J W van Kraaij, Michael R Hamblin, Gisele Pickering, et al.
Experimental Dermatology|July 24, 2023
Reflectance confocal microscopy as a non-invasive imaging tool in vulvar high-grade squamous intraepithelial lesions and lichen sclerosus: A descriptive morphological study in patients and healthy volunteersBertine W Huisman, Lisa Pagan, Martina Ulrich, et al.
Clinical and Experimental Dermatology|July 20, 2024
Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trialVazula Z Bekkers, Katarzyna M Zdunczyk, Liora Bik, et al.
Clinical and Translational Science|May 17, 2018
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug DevelopmentTessa van der Kolk, Salma Assil, Rianne Rijneveld, et al.
Frontiers in Pharmacology|June 26, 2023
The impact of <i>CYP2C19</i> genotype on phenoconversion by concomitant medicationLaura M de Jong, Soukayna Boussallami, Elena Sánchez-López, et al.
Microorganisms|December 24, 2021
The Human Vulvar Microbiome: A Systematic ReviewLisa Pagan, Roos A M Ederveen, Bertine W Huisman, et al.
Clinical Immunology (Orlando, Fla.)|November 24, 2016
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasisDeepak M W Balak, Martijn B A van Doorn, Robert D Arbeit, et al.
Clinical and Translational Science|March 21, 2024
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteersStefan J Jodl, Wouter Ten Voorde, Stefan Klein, et al.
Toxicology Research|July 5, 2022
Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (<sup>26</sup>Al)Al microtracer approach: a follow-up study in humansRianne de Ligt, Joost Westerhout, Dimitri Grossouw, et al.
British Journal of Clinical Pharmacology|February 21, 2017
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamineAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Robert Rissmann, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Experimental Dermatology|November 11, 2023
A Phase 1 randomized, open-label clinical trial to evaluate the effect of a far-infrared emitting patch on local skin perfusion, microcirculation and oxygenationSebastiaan J W van Kraaij, Michael R Hamblin, Gisele Pickering, et al.
Experimental Dermatology|July 24, 2023
Reflectance confocal microscopy as a non-invasive imaging tool in vulvar high-grade squamous intraepithelial lesions and lichen sclerosus: A descriptive morphological study in patients and healthy volunteersBertine W Huisman, Lisa Pagan, Martina Ulrich, et al.
Clinical and Experimental Dermatology|July 20, 2024
Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trialVazula Z Bekkers, Katarzyna M Zdunczyk, Liora Bik, et al.
Clinical and Translational Science|May 17, 2018
Comprehensive, Multimodal Characterization of an Imiquimod-Induced Human Skin Inflammation Model for Drug DevelopmentTessa van der Kolk, Salma Assil, Rianne Rijneveld, et al.
Frontiers in Pharmacology|June 26, 2023
The impact of <i>CYP2C19</i> genotype on phenoconversion by concomitant medicationLaura M de Jong, Soukayna Boussallami, Elena Sánchez-López, et al.
Microorganisms|December 24, 2021
The Human Vulvar Microbiome: A Systematic ReviewLisa Pagan, Roos A M Ederveen, Bertine W Huisman, et al.
Clinical Immunology (Orlando, Fla.)|November 24, 2016
IMO-8400, a toll-like receptor 7, 8, and 9 antagonist, demonstrates clinical activity in a phase 2a, randomized, placebo-controlled trial in patients with moderate-to-severe plaque psoriasisDeepak M W Balak, Martijn B A van Doorn, Robert D Arbeit, et al.
Clinical and Translational Science|March 21, 2024
The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteersStefan J Jodl, Wouter Ten Voorde, Stefan Klein, et al.
Toxicology Research|July 5, 2022
Assessment of dermal absorption of aluminium from a representative antiperspirant formulation using a (<sup>26</sup>Al)Al microtracer approach: a follow-up study in humansRianne de Ligt, Joost Westerhout, Dimitri Grossouw, et al.
British Journal of Clinical Pharmacology|February 21, 2017
An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamineAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Robert Rissmann, et al.
Pageof 10